$ABT ABBOTT LABORATORIES Insider Trading Week 16/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ABBOTT LABORATORIES in week 16/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 38.40 | 63,200 | 2,426,880 | 20,133 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 96.26 | 39,234 | 3,776,630 | 66,445 | 105.7 K to 66.4 K (-37.13 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 95.57 | 23,966 | 2,290,421 | 105,679 | 129.6 K to 105.7 K (-18.49 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 38.40 | 63,200 | 2,426,880 | 129,645 | 66.4 K to 129.6 K (+95.12 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 22.39 | 50,100 | 1,121,834 | 0 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 96.28 | 18,701 | 1,800,596 | 316,800 | 335.5 K to 316.8 K (-5.57 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 95.63 | 31,399 | 3,002,730 | 335,501 | 366.9 K to 335.5 K (-8.56 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 22.39 | 50,100 | 1,121,834 | 366,900 | 316.8 K to 366.9 K (+15.81 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Scoggins Christopher J | Senior Vice Preside ... | Sell | S | 96.10 | 414 | 39,785 | 39,706 | 40.1 K to 39.7 K (-1.03 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Option Exercise | M | 38.40 | 63,200 | 2,426,880 | 20,133 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 39.12 | 13,000 | 508,560 | 31,325 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 96.26 | 39,234 | 3,776,630 | 66,445 | 105.7 K to 66.4 K (-37.13 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 34.94 | 23,700 | 828,078 | 0 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Sell | S | 95.57 | 23,966 | 2,290,421 | 105,679 | 129.6 K to 105.7 K (-18.49 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Payment of Exercise | F | 98.00 | 23,855 | 2,337,790 | 182,217 | 206.1 K to 182.2 K (-11.58 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Ginascol John F | Executive Vice Pres ... | Buy | M | 38.40 | 63,200 | 2,426,880 | 129,645 | 66.4 K to 129.6 K (+95.12 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 39.12 | 13,000 | 508,560 | 206,072 | 193.1 K to 206.1 K (+6.73 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 22.39 | 50,100 | 1,121,834 | 0 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 34.94 | 23,700 | 828,078 | 193,072 | 169.4 K to 193.1 K (+13.99 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 96.28 | 18,701 | 1,800,596 | 316,800 | 335.5 K to 316.8 K (-5.57 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 95.63 | 31,399 | 3,002,730 | 335,501 | 366.9 K to 335.5 K (-8.56 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 22.39 | 50,100 | 1,121,834 | 366,900 | 316.8 K to 366.9 K (+15.81 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Scoggins Christopher J | Senior Vice Preside ... | Sell | S | 96.10 | 414 | 39,785 | 39,706 | 40.1 K to 39.7 K (-1.03 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 39.12 | 13,000 | 508,560 | 31,325 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Option Exercise | M | 34.94 | 23,700 | 828,078 | 0 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Payment of Exercise | F | 98.00 | 23,855 | 2,337,790 | 182,217 | 206.1 K to 182.2 K (-11.58 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 39.12 | 13,000 | 508,560 | 206,072 | 193.1 K to 206.1 K (+6.73 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Funck Robert E | Executive Vice Pres ... | Buy | M | 34.94 | 23,700 | 828,078 | 193,072 | 169.4 K to 193.1 K (+13.99 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 75.90 | 25,681 | 1,949,188 | 51,364 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 59.94 | 36,715 | 2,200,697 | 36,715 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 44.40 | 46,016 | 2,043,110 | 0 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 98.00 | 83,226 | 8,156,148 | 62,205 | 145.4 K to 62.2 K (-57.23 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 75.90 | 25,681 | 1,949,188 | 145,431 | 119.8 K to 145.4 K (+21.45 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 59.94 | 36,715 | 2,200,697 | 119,750 | 83 K to 119.8 K (+44.22 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 44.40 | 46,016 | 2,043,110 | 83,035 | 37 K to 83 K (+124.30 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 75.90 | 25,681 | 1,949,188 | 51,364 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 59.94 | 36,715 | 2,200,697 | 36,715 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 44.40 | 46,016 | 2,043,110 | 0 | |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Payment of Exercise | F | 98.00 | 83,226 | 8,156,148 | 62,205 | 145.4 K to 62.2 K (-57.23 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 75.90 | 25,681 | 1,949,188 | 145,431 | 119.8 K to 145.4 K (+21.45 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 59.94 | 36,715 | 2,200,697 | 119,750 | 83 K to 119.8 K (+44.22 %) |
| Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 44.40 | 46,016 | 2,043,110 | 83,035 | 37 K to 83 K (+124.30 %) |